1. Disorders of sex development (DSD) are conditions where the development of chromosomal, gonadal, or anatomic sex is atypical.
2. Evaluation of a newborn with suspected DSD involves assessing the genitalia, family history, karyotype, hormone levels, and imaging to determine the underlying condition and guide gender assignment and long-term management.
3. The most common DSD is congenital adrenal hyperplasia due to 21-hydroxylase deficiency, presenting in 46,XX newborns with virilization. Initial treatment focuses on hormone replacement and monitoring for salt-wasting crises, while long-term management involves gender assignment, surgical interventions, and
Congenital Adrenal Hyperplasia (CAH)
For 5th Year Medical Students and Endocrinology Modules and Master and MD Degree Internal Medicine and Endocrinology
By Dr Usama Ragab Youssif
References: Oxford Handbook of Endocrinology & Diabetes
Congenital Adrenal Hyperplasia (CAH)
For 5th Year Medical Students and Endocrinology Modules and Master and MD Degree Internal Medicine and Endocrinology
By Dr Usama Ragab Youssif
References: Oxford Handbook of Endocrinology & Diabetes
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
1. Approach to Disorders of sex
development
Dr Bhupendra Kuma Gupta
Dept of Neonatology
IPGME &R SSKM hospital
2. Definition
• Disorders of sex development (DSD) are
heterogeneous group of disorders defined by
atypical development of genetic,gonadal and
anatomic sex
4. DSD presentation in the newborn
• Ambiguous genitalia
• Cryptorchidism
• Unilateral cryptorchidism with hypospadias
• Penoscrotal, scrotal or perineal hypospadias
with or without microphallus
5. .
• Apparently female appearance with
clitoromegaly and/or inguinal hernia or
palpable gonad
• Asymmetry of in size, pigmentation or
rugation of labioscrotal folds
• Discordance of external genitalia with
prenatal karyotype
7. .
• Undifferentiated gonads develop in the
bilateral genital ridges around 6 weeks of
gestation and begin to differentiate by 7
weeks.
• SRY which encodes the primary testis-
determining transcription factor on the short
arm of the Y chromosome promotes the
gonads to develop into testes.
9. .
• In the XY gonad SRY expression is initiated by
WT1/GATA4/FOG which leads to the up
regulation of SOX9 expression via synergy with
NR5A1.
• Once SOX9 levels reach a critical threshold
SOX9 auto regulates its own expression.
• In the XX gonad RSPO1/WNT4 represses SOX9
expression.
10. Anatomic sex
• Refers to the external and internal genitalia
• Testis secretes two hormones critical for male
genital formation
• Anti-mullerian hormone produced by Sertoli
cells
• Testosterone produced by Leydig cells
11. Internal genitalia
• AMH causes regression of the mullerian ducts
that would otherwise become uterus,fallopian
tubes, cervix, and upper vagina.
• Testosterone prevents the regression of the
wolffian ducts and promotes their
development into the vas deferens, seminal
vesicles and epididymis.
12. .
• Mullerian duct regression and wolffian duct
development require high local concentrations
of AMH and testosterone respectively.
• Failure of a testis to develop on one side may
result in ipsilateral retention of mullerian
structures and regression of wolffian
structures
14. External genitalia
• The enzyme 5α-reductase present in high
concentration in genital skin, converts
testosterone to dihydrotestosterone (DHT).
• DHT is the primary hormone responsible for
masculinizing the external genitalia including
the genital tubercle and labioscrotal folds
which form the penis and scrotum
respectively.
15. .
• In the absence of DHT these undifferentiated
structures develop into the clitoris and labia.
• Testicular descent from the abdomen to the
inguinal ring requires insulin-like peptide 3
(INSL3) and descent from the inguinal ring into
the scrotum requires testosterone.
• Formation of normal male internal and
external genitalia under the influence of
testosterone and DHT requires functional
androgen receptors in the target tissues.
17. Time course
First trimester
• Testicular synthesis of testosterone is
stimulated by activation of the luteinizing
hormone (LH) receptor by human chorionic
gonadotropin (hCG) produced by the placenta.
• The first trimester is the only period during
which the labioscrotal folds are susceptible to
fusion.
18. .
• If a 46,XX fetus is exposed to excess
androgens during the first trimester the
clitoris and labioscrotal folds will virilize and
may appear indistinguishable from a normal
male penis and scrotum although the latter
will be empty
19. Second and third trimesters
• Testicular androgen production is stimulated
by LH from the fetal pituitary and is
responsible for penile growth, scrotal
maturation (rugation, pigmentation and
thinning) and final testicular descent.
• High intrauterine concentrations of
testosterone may influence brain
development possibly affecting later behavior
sexual orientation and gender identity
27. .
History
Maternal drug exposure
• Androgens (testosterone, danazol)
• Drugs that interfere with androgen synthesis
or action (finasteride)
• Maternal virilization during pregnancy due to
poorly controlled maternal CAH, a virilizing
adrenal or ovarian tumor
28. .
• Family history of CAH, hypospadias
cryptorchidism, infertility, pubertal delay,
corrective genital surgery,genetic syndromes,
or consanguinity.
• Death of a male family member from vomiting
or dehydration in early infancy may suggest
undiagnosed CAH
29. Physical examination
• Stretched penile length,presence of chordee
position of the urethral orifice,presence of
vaginal opening ,pigmentation and symmetry
of the scrotum or labioscrotal folds.
• Normal full-term male infant has a penile
length of at least 2.5 cm, measured stretched
from the pubic ramus to the tip of the glans
and usually 1 cm or more in width
34. .
• The normal full-term female infant has a
clitoris <1 cm in length and <0.5 cm in width
• Posterior fusion of the labioscrotal folds is
assessed by determining the anogenital ratio
which is the distance between the anus and
the posterior fourchette divided by the
distance between the anus and the base of
the phallus.
• An anogenital ratio >0.5 indicates first-
trimester androgen exposure
35. .
• Gonadal size, position, and descent should be
noted.
• A gonad below the inguinal ligament is usually
a testis (normal or dysgenetic) but may be an
ovotestis or even a uterus herniating into the
inguinal canal.
• Abnormal genital development with bilateral
nonpalpable gonads should raise immediate
concern for salt wasting CAH
39. Associated anomalies
• Denys-Drash syndrome (Wilms tumor and
diffuse glomerulosclerosis)
• WAGR (Wilms tumor, Aniridia, Genitourinary
anomalies and mental Retardation) syndrome
• Other conditions associated with DSD include
smith-lemli-opitz, Robinow, Antley-Bixler and
Goldenhar syndromes, campomelic dysplasia
and trisomy 13
40. .
• .
Neonate with suspected DSD
Gonads palpable
Unilateral BilateralNo
Possible undrevirilised
male XY DSD
Possible mixed gonadal
dysgenesis,ovotesticular DSD
Possible virilised
female XX DSD
43. CAH
• The most common DSD presenting in the
neonatal period is a 46,XX infant with CAH.
• The most common form of CAH (>90%) is
deficiency of 21-hydroxylase (21-OHase) caused
by mutations in CYP21A2.
• Rarer forms of CAH due to deficiency of 11β-
hydroxylase or 3β-hydroxysteroid dehydrogenase
• Individuals with CAH typically do not have
testicular tissue and therefore usually have
normally developed mullerian structures and no
wolffian structures
44. .
• Incidence of 21-OHase deficiency is 1:16,000
• Patients with salt wasting out number those
with simple virilizing CAH by 3:1.
• The male:female sex ratio is 1:1
• Females are easily detected at birth due to
abnormal genital development
• Males have normal genitalia and may be
missed on clinical exam (although hyper
pigmentation of the scrotum can be a clue).
45. .
• In an infant with 11-OHase deficiency levels
of 11-deoxycortisol and 11 deoxy
corticosterone are elevated and can cause
hypertension.
• An infant with 3β-HSD deficiency may have
mildly elevated 17-OHP on newborn screen
46. .
• First-line investigation
• Karyotyping/FISH
• Serum electrolytes,RBS
• USG for Mullerian structures and gonads
• Sr 17-OHP
47. Interpretation of 17-OHP
1.Unaffected <15 nmol/L
2.21 hydroxylase deficiency > 300-800 nmol/L
3. 11 beta OH and 3 beta OH deficiency 15-100
nmol/L
Prematurity ,sampling prior to 48 hours of life
and neonatal stress can cause 17-OHP as high as
100 nmol/L
48. Pelvic ultrasonography
• Determine whether uterus is present.
• Testes can often be visualized by ultrasound
but ovaries are less likely to be identified.
• Given the association between urologic and
genital malformations, ultrasonographic
evaluation should include the kidneys, ureters,
and bladder.
• Adrenal hyperplasia can often be found in
babies with CAH but is not diagnostic
49. .
Second line investigations
• Sr testosterone,dihydrotestosterone
• FSH,LH
• AMH
• 11-deoxycortisol
• HCG stimulation test
• Genitogram and laproscopy
50. Management
Gender assignment
• After the preliminary investigations and karyotyping
1. Female assignment
a. 46 XX and CAH
b. Complete AIS
• Male assignment
a.5 alpha reductase deficiency
b.17 beta HSD 3 deficiency
51. .
For ovotesticular DSD
• Difficult to assign gender in the neonatal
period
• Multiple factors have to be taken into account
including anticipated quality of sexual
function,surgical options,fertility potential
52. CAH management
• These neonates can present as medical
emergency (salt wasting crisis)
• Salt-wasting crises usually develop between the
5th and 14th day of life but can occur as late as 1
month and may occur even in affected infants
whose virilization is not severe.
• Weight, fluid balance, and electrolytes must be
monitored closely with blood samples at least
every 2 days during the first few weeks of life to
detect hyponatremia or hyperkalemia
54. Definitive treatment DSD
Hormonal treatment
• Testosterone in case of micro phallus
• Pubertal estrogen and progestin in female
gender assignment
55. .
Surgical treatment
• Definitive surgery should only be consider
once psychological factors, adult gender
identity, fertility potential and individual own
preference of sexual activity is ensured and
discussed with reasonable level of surety
56. Prognosis
• Risk of future tumor development and fertility
are two important prognostic factor
• Risk of gonadoblastoma,dysgerminoma and
seminoma is present in XY intra abdominal
gonads
• Fertility may be possible utilising sperm retrieval
and ICSI in pt with functional gonads
• In female ovulation induction and embryo
transfer using donated ova have been used in
CAH and Turner syndrome